gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors - PubMed (original) (raw)
gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors
M V Catani et al. J Neurochem. 2000 Jun.
Free article
Abstract
To infect target cells, the human immunodeficiency virus (HIV) type I (HIV-1) must engage not only the well-known CD4 molecule, but it also requires one of several recently described coreceptors. In particular, the CXCR4 (LESTR/fusin) receptor allows fusion and entry of T-tropic strains of HIV, whereas CCR5 is the major coreceptor used by primary HIV-1 strains that infect macrophages and CD4(+) T-helper cells (M-tropic viruses). In addition, the alpha chemokine SDF1alpha and the beta chemokines MIP1alpha, MIP1beta, and RANTES, natural ligands of CXCR4 and CCR5, respectively, are potent soluble inhibitors of HIV infection by blocking the binding between the viral envelope glycoprotein gp120 and the coreceptors. Approximately two-thirds of individuals with acquired immunodeficiency syndrome (AIDS) show neurologic complications, which are referred to a syndrome called AIDS dementia complex or HIV-1-associated cognitive/motor complex. The HIV-1 coat glycoprotein gp120 has been proposed as the major etiologic agent for neuronal damage, mediating both direct and indirect effects on the CNS. Furthermore, recent findings showing the presence of chemokine receptors on the surface of different cell types resident in the CNS raise the possibility that the association of gp120 with these receptors may contribute to the pathogenesis of neurological dysfunction. Here, we address the possible role of alpha and beta chemokines in inhibiting gp120-mediated neurotoxicity using the human neuroblastoma CHP100 cell line as an experimental model. We have previously shown that, in CHP100 cells, picomolar concentrations of gp120 produce a significant increase in cell death, which seems to proceed through a Ca(2+) - and NMDA receptor-dependent cascade. In this study, we gained insight into the mechanism(s) of neurotoxicity elicited by the viral glycoprotein. We found that CHP100 cells constitutively express both CXCR4 and CCR5 receptors and that stimulation with phorbol 12-myristate 13-acetate down-regulates their expression, thus preventing gp120-induced cell death. Furthermore, all the natural ligands of these receptors exerted protective effects against gp120-mediated neuronal damage, although with different efficiencies. These findings, together with our previous reports, suggest that the neuronal injury observed in HIV-1 infection could be due to direct (or indirect) interactions between the viral protein gp120 and chemokine and/or NMDA receptors.
Similar articles
- Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
Lee S, Lapham CK, Chen H, King L, Manischewitz J, Romantseva T, Mostowski H, Stantchev TS, Broder CC, Golding H. Lee S, et al. J Virol. 2000 Jun;74(11):5016-23. doi: 10.1128/jvi.74.11.5016-5023.2000. J Virol. 2000. PMID: 10799575 Free PMC article. - Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4.
Cho MW, Lee MK, Carney MC, Berson JF, Doms RW, Martin MA. Cho MW, et al. J Virol. 1998 Mar;72(3):2509-15. doi: 10.1128/JVI.72.3.2509-2515.1998. J Virol. 1998. PMID: 9499115 Free PMC article. - Chemokine receptor utilization and macrophage signaling by human immunodeficiency virus type 1 gp120: Implications for neuropathogenesis.
Yi Y, Lee C, Liu QH, Freedman BD, Collman RG. Yi Y, et al. J Neurovirol. 2004;10 Suppl 1:91-6. doi: 10.1080/753312758. J Neurovirol. 2004. PMID: 14982745 Review. - HIV-1 infection and chemokine receptor modulation.
Ruibal-Ares BH, Belmonte L, Baré PC, Parodi CM, Massud I, de Bracco MM. Ruibal-Ares BH, et al. Curr HIV Res. 2004 Jan;2(1):39-50. doi: 10.2174/1570162043484997. Curr HIV Res. 2004. PMID: 15053339 Review.
Cited by
- Solving the Blood-Brain Barrier Challenge for the Effective Treatment of HIV Replication in the Central Nervous System.
Bertrand L, Nair M, Toborek M. Bertrand L, et al. Curr Pharm Des. 2016;22(35):5477-5486. doi: 10.2174/1381612822666160726113001. Curr Pharm Des. 2016. PMID: 27464720 Free PMC article. Review. - Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?
Fulop T, Witkowski JM, Larbi A, Khalil A, Herbein G, Frost EH. Fulop T, et al. J Neurovirol. 2019 Oct;25(5):634-647. doi: 10.1007/s13365-019-00732-3. Epub 2019 Mar 13. J Neurovirol. 2019. PMID: 30868421 Review. - Pathogenic mechanisms of human immunodeficiency virus (HIV)-associated pain.
Liu X, Tang SJ. Liu X, et al. Mol Psychiatry. 2023 Sep;28(9):3613-3624. doi: 10.1038/s41380-023-02294-7. Epub 2023 Oct 19. Mol Psychiatry. 2023. PMID: 37857809 Review. - CCR5 deficiency: Decreased neuronal resilience to oxidative stress and increased risk of vascular dementia.
Tournier BB, Sorce S, Marteyn A, Ghidoni R, Benussi L, Binetti G, Herrmann FR, Krause KH, Zekry D. Tournier BB, et al. Alzheimers Dement. 2024 Jan;20(1):124-135. doi: 10.1002/alz.13392. Epub 2023 Jul 25. Alzheimers Dement. 2024. PMID: 37489764 Free PMC article. - HIV-associated synaptic degeneration.
Ru W, Tang SJ. Ru W, et al. Mol Brain. 2017 Aug 29;10(1):40. doi: 10.1186/s13041-017-0321-z. Mol Brain. 2017. PMID: 28851400 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous